Home - Products - Others - Other Targets - (2E,4E)-hexa-2,4-dien-1-yl acetate

(2E,4E)-hexa-2,4-dien-1-yl acetate

CAS No. 57006-69-6

(2E,4E)-hexa-2,4-dien-1-yl acetate( —— )

Catalog No. M37379 CAS No. 57006-69-6

(2E,4E)-hexa-2,4-dien-1-yl acetate is an intermediate of the sex pheromone of the codling moth.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 276 In Stock
10MG 394 In Stock
25MG 616 In Stock
50MG 830 In Stock
100MG 1097 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (2E,4E)-hexa-2,4-dien-1-yl acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    (2E,4E)-hexa-2,4-dien-1-yl acetate is an intermediate of the sex pheromone of the codling moth.
  • Description
    (2E,4E)-hexa-2,4-dien-1-yl acetate is an intermediate of the sex pheromone of the codling moth.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    57006-69-6
  • Formula Weight
    140.18
  • Molecular Formula
    C8H12O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(/C=C/C=C/C)OC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Angiogenin 108-122

    Angiogenin (108-122) is an angiogenin peptide. Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmune disease, or a heart and vascular disease.

  • Glycyl-L-valine

    Glycyl-L-valine is a dipeptide composed of glycine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism.

  • TDRL-551

    TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 μM) with potential anticancer activity.